LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 192 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $50,588,000 | +11.8% | 472,386 | +12.9% | 0.09% | +12.7% |
| Q4 2015 | $45,266,000 | +42.3% | 418,475 | +12.7% | 0.08% | +33.9% |
| Q3 2015 | $31,814,000 | -3.4% | 371,436 | +13.8% | 0.06% | +11.3% |
| Q2 2015 | $32,944,000 | +14.7% | 326,514 | -12.4% | 0.05% | 0.0% |
| Q1 2015 | $28,732,000 | +62.4% | 372,609 | +10.0% | 0.05% | +71.0% |
| Q4 2014 | $17,696,000 | +19.7% | 338,855 | +7.7% | 0.03% | +19.2% |
| Q3 2014 | $14,782,000 | +36.7% | 314,559 | +43.2% | 0.03% | +36.8% |
| Q2 2014 | $10,816,000 | -14.4% | 219,635 | +16.9% | 0.02% | -13.6% |
| Q1 2014 | $12,633,000 | +21.7% | 187,814 | +9.1% | 0.02% | +15.8% |
| Q4 2013 | $10,378,000 | +273.4% | 172,129 | +168.0% | 0.02% | +280.0% |
| Q3 2013 | $2,779,000 | 0.0% | 64,223 | -13.5% | 0.01% | 0.0% |
| Q2 2013 | $2,779,000 | – | 74,229 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |